相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。STATIN-ASSOCIATED CHANGES IN SKELETAL MUSCLE FUNCTION AND STRESS RESPONSE AFTER NOVEL OR ACCUSTOMED EXERCISE
Benjamin M. Meador et al.
MUSCLE & NERVE (2011)
Vasomodulatory effect of novel peroxovanadate compounds on rat aorta: Role of rho kinase and nitric oxide/cGMP pathway
Vivek Khanna et al.
PHARMACOLOGICAL RESEARCH (2011)
Detection of reactive oxygen species (ROS) by the oxidant-sensing probe 2′,7′-dichlorodihydrofluorescein diacetate in the cyanobacterium Anabaena variabilis PCC 7937
Rajesh P. Rastogi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Atorvastatin inhibits inflammatory angiogenesis in mice through down regulation of VEGF, TNF-alpha and TGF-beta 1
F. A. Araujo et al.
BIOMEDICINE & PHARMACOTHERAPY (2010)
Inflammatory and thrombotic processes are associated with vascular dysfunction in children with familial hypercholesterolemia
Marietta Charakida et al.
ATHEROSCLEROSIS (2009)
Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo
Stefania Momi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Comparison effect of atorvastatin (10 versus 80 mg) on biomarkers of inflammation and oxidative stress in subjects with metabolic syndrome
Uma Singh et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
The role of eNOS, iNOS, and NF-κB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin
Yumei Ye et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Effect of atorvastatin on hs-CRP in acute coronary syndrome
Ankur Gupta et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Dose translation from animal to human studies revisited
Shannon Reagan-Shaw et al.
FASEB JOURNAL (2008)
Effect of alcohol and tobacco smoke on mtDNA damage and atherogenesis
Yavuz Cakir et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties
Stefania Momi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Mouse models for atherosclerosis and pharmaceutical modifiers
Susanne Zadelaar et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia
H. J. Avis et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Oxidative stress-mediated platelet CD40 ligand upregulation in patients with hypercholesterolemia: effect of atorvastatin
P. Pignatelli et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Antiatherogenic effects of S-nitroso-N-acetylcysteine in hypercholesterolemic LDL receptor knockout mice
MH Krieger et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2006)
A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression
MR Rossiello et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Rho and vascular disease
BE Rolfe et al.
ATHEROSCLEROSIS (2005)
Isoprostanes and other markers of peroxidation in atherosclerosis
P Patrignani et al.
BIOMARKERS (2005)
Intraplatelet signaling mechanisms of the priming effect of matrix metal loproteinase-2 on platelet aggregation
E Falcinelli et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients
S John et al.
AMERICAN HEART JOURNAL (2005)
Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice
K Wouters et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2005)
Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors
T Wæhre et al.
CIRCULATION (2004)
Increase in serum amyloid A evoked by dietary cholesterol is associated with increased atherosclerosis in mice
KE Lewis et al.
CIRCULATION (2004)
Nitric oxide (NO)-releasing statin derivatives, a class of drugs showing enhanced anti proliferative and antiinflammatory properties
E Ongini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Inflammation and restenosis after percutaneous coronary interventions
K Toutouzas et al.
EUROPEAN HEART JOURNAL (2004)
Inhibition of hepatocyte lipogenesis by nitric oxide donor: Could nitric oxide regulate lipid synthesis?
WE Roediger et al.
IUBMB LIFE (2004)
High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study
S Kinlay et al.
CIRCULATION (2003)
Correlates of endothelial function and their relationship with inflammation in patients with familial hypercholesterolaemia
PL van Haelst et al.
CLINICAL SCIENCE (2003)
Endothelium dysfunction in LDL receptor knockout mice:: a role for H2O2
LA Rabelo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Effects of chronic treatment with L-arginine on atherosclerosis in ApoE knockout and ApoE/inducible NO synthase double-knockout mice
JQ Chen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Early statin therapy restores endothelial function in children with familial hypercholesterolemia
S de Jongh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease
P Minuz et al.
CIRCULATION (2002)
Effects of atorvastatin treatment on sICAM-1 and plasma nitric oxide levels in hypercholesterolemic subjects
MA Sardo et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2002)
Cellular antioxidant effects of atorvastatin in vitro and in vivo
S Wassmann et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Nitric oxide-dependent nitrosation of cellular CoA: A proposal for tissue responses
WEW Roediger
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2001)
Circulating interleukin-1 beta, interleukin-6, tumor necrosis factor-alpha, and soluble ICAM-1 in patients with chronic stable angina and myocardial infarction
Y Balbay et al.
ANGIOLOGY (2001)
Angioplasty increases coronary sinus F-2-isoprostane formation: Evidence for in vivo oxidative stress during PTCA
L Iuliano et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice
U Laufs et al.
STROKE (2000)
Nitric oxide effect on colonocyte metabolism: Co-action of sulfides and peroxide
WE Roediger et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2000)